Dendritic cell vaccine - Bioclones/Hemispherx BiopharmaAlternative Names: Cancer vaccine - Bioclones; Patient-specific DC immunotherapy vaccine - Bioclones/Hemispherx Biopharma
Latest Information Update: 18 Jul 2014
At a glance
- Originator Bioclones
- Developer Bioclones; Hemispherx Biopharma
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Cancer
- Preclinical Breast cancer; Prostate cancer